These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Lyu T; Lee YS; Dhanvijay S; Freebairn R Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324 [TBL] [Abstract][Full Text] [Related]
4. Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials. Tarazan N; Alshehri M; Sharif S; Al Duhailib Z; Møller MH; Belley-Cote E; Alshahrani M; Centofanti J; McIntyre L; Baw B; Meade M; Alhazzani W; Intensive Care Med Exp; 2020 Oct; 8(1):61. PubMed ID: 33095344 [TBL] [Abstract][Full Text] [Related]
5. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis. Hua Y; Ou X; Li Q; Zhu T PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896 [TBL] [Abstract][Full Text] [Related]
7. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome. Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M; Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014 [TBL] [Abstract][Full Text] [Related]
8. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. ; Moss M; Huang DT; Brower RG; Ferguson ND; Ginde AA; Gong MN; Grissom CK; Gundel S; Hayden D; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Khan A; Liu KD; Talmor D; Thompson BT; Ulysse CA; Yealy DM; Angus DC N Engl J Med; 2019 May; 380(21):1997-2008. PubMed ID: 31112383 [TBL] [Abstract][Full Text] [Related]
9. Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation. Kressin C; Thompson Bastin M; Ather A; Gopinath A; Srour H; Schadler A; Pandya K J Clin Pharmacol; 2021 Nov; 61(11):1415-1420. PubMed ID: 34180067 [TBL] [Abstract][Full Text] [Related]
10. Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for Treatment of Acute Respiratory Distress Syndrome-A Retrospective Cohort Study From a New England Health Care Network. Wongtangman K; Grabitz SD; Hammer M; Wachtendorf LJ; Xu X; Schaefer MS; Fassbender P; Santer P; Kassis EB; Talmor D; Eikermann M; Crit Care Med; 2021 Jul; 49(7):1137-1148. PubMed ID: 33710031 [TBL] [Abstract][Full Text] [Related]
11. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials. Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488 [TBL] [Abstract][Full Text] [Related]
12. Prone position for acute respiratory failure in adults. Bloomfield R; Noble DW; Sudlow A Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008095. PubMed ID: 26561745 [TBL] [Abstract][Full Text] [Related]
13. The use of early neuromuscular blockage in acute respiratory distress syndrome: A systematic review and meta-analyses of randomized clinical trials. Savoie-White FH; Tremblay L; Menier CA; Duval C; Bergeron F; Tadrous M; Tougas J; Guertin JR; Ugalde PA Heart Lung; 2023; 57():186-197. PubMed ID: 36242824 [TBL] [Abstract][Full Text] [Related]
14. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression. Shao S; Kang H; Tong Z BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180 [TBL] [Abstract][Full Text] [Related]
15. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). Chacko B; Peter JV; Tharyan P; John G; Jeyaseelan L Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008807. PubMed ID: 25586462 [TBL] [Abstract][Full Text] [Related]
16. Is high-frequency oscillatory ventilation more effective and safer than conventional protective ventilation in adult acute respiratory distress syndrome patients? A meta-analysis of randomized controlled trials. Gu XL; Wu GN; Yao YW; Shi DH; Song Y Crit Care; 2014 May; 18(3):R111. PubMed ID: 24887179 [TBL] [Abstract][Full Text] [Related]
17. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome. Needham CJ; Brindley PG Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702 [TBL] [Abstract][Full Text] [Related]
18. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients. Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Cisatracurium Versus Atracurium in Early ARDS. Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905 [TBL] [Abstract][Full Text] [Related]
20. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome. Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]